An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2018
At a glance
- Drugs Itacitinib (Primary) ; Methylprednisolone; Prednisolone
- Indications Graft-versus-host disease
- Focus Adverse reactions
- Sponsors Incyte Corporation
- 25 Oct 2018 Planned End Date changed from 1 Apr 2019 to 1 Aug 2019.
- 25 Oct 2018 Planned primary completion date changed from 1 Apr 2019 to 1 Aug 2019.
- 17 Apr 2018 New trial record